Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05980130 · ClinicalTrials.gov registry record · NA
Can Rumination-Focused Cognitive Behavioral Therapy Reduce the Risk of Cardio-vascular Disease?
A NA study of Blood Pressure and Depressive Symptoms, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT05980130: Completed NA study of Blood Pressure and Depressive Symptoms, sponsored by University of Louisville.
NCT05980130 is a NA study of Blood Pressure and Depressive Symptoms that has completed, run by University of Louisville. The registered enrollment target is 9 participants, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05980130, a NA study of Blood Pressure and Depressive Symptoms, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
Many people know that a poor diet, exercise, smoking, and alcohol use cause heart disease. However, a less known factor that increases the risk of heart disease is depression. In addition, heart disease can also make depression worse. Almost half of American adults have some form of heart disease. Patients with low income are at an even greater risk. The circular relation between depression and heart disease raises the question of whether or not there are factors that lead to both. Attacking a factor that affects both depression and heart disease could help prevent them both. One such factor is rumination which is when someone tends to have repeated negative thoughts that loop without end. This loop in turn tears and wears down the body over time, making the person be at risk for heart disease and depression. Rumination-Focused Cognitive Behavioral Therapy (RFCBT) is a tool that targets rumination and, by doing so, reduces the risk for depression. While research has shown RFCBT helps to reduce or stop the loop that leads to depression, this project will further look at the effect of RFCBT on measures of heart health persons with low income.
Primary Outcome
sadness rumination, Score range: 5-20, higher score = more rumination
Conditions Studied
Interventions
- BEHAVIORAL Rumination-Focused Cognitive Behavior Therapy
Study Locations (1)
Kentucky
- Have a Heart clinic - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2025-09-12 |
| Phase | NA |
What the finished NCT05980130 record still lists
NCT05980130 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 287-participant average among 101 other Blood Pressure trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Blood Pressure appearing as the primary indexed condition, and to 1 intervention - of which Rumination-Focused Cognitive Behavior Therapy is the first listed.
NCT05980130 reports a single indexed study location in Kentucky.
Frequently Asked Questions
What is clinical trial NCT05980130 about?
NCT05980130 is a clinical study titled "Can Rumination-Focused Cognitive Behavioral Therapy Reduce the Risk of Cardio-vascular Disease?". Many people know that a poor diet, exercise, smoking, and alcohol use cause heart disease. However, a less known factor that increases the risk of heart disease is depression. In addition, heart disease can also make depression worse. Almost half of American adults have some form of heart disease. P...
What is the current status of trial NCT05980130?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-08-15. Estimated completion is 2025-09-12.
What conditions does trial NCT05980130 study?
This clinical trial studies the following conditions: Blood Pressure, Depressive Symptoms, Rumination.
What interventions are being tested in trial NCT05980130?
The interventions under investigation include: Rumination-Focused Cognitive Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05980130?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05980130 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05980130's enrollment target sits among peer trials
9 100th of 101 higher than 2 of 101 other Blood Pressure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Blood Pressure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Cocooned Moms Study
RECRUITING · NA
-
The GUARDIAN Trial
RECRUITING · NA
-
The Venous Distension Reflex and Orthostatic Hypertension
RECRUITING · NA
-
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
RECRUITING · NA
-
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI